What is the price target for INTS stock?
12 analysts have analysed INTS and the average price target is 57.29 USD. This implies a price increase of 1005.98% is expected in the next year compared to the current price of 5.18.
INTENSITY THERAPEUTICS INC (INTS) Forecast, Price Target & Analyst Ratings
NASDAQ:INTS • US45828J2024
Current stock price
5.18 USD
+0.03 (+0.58%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTENSITY THERAPEUTICS INC (INTS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.11
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$57.29
Upside
+ 1,005.99%
From current price of $5.18 to mean target of $57.29, Based on 12 analyst forecasts
Low
$12.12
Median
$53.55
High
$131.25
Price Target Revisions
1 Month
-22.97%
3 Months
1,825.69%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for INTS. The average price target is 57.29 USD. This implies a price increase of 1005.98% is expected in the next year compared to the current price of 5.18.
The average price target has been revised upward by 1825.69% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.67%
INTS was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about INTS.
In the previous month the buy percentage consensus was at a similar level.
INTS was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-20 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-08-12 | Brookline Capital | Upgrade | Hold -> Buy |
| 2025-01-13 | Alliance Global Partners | Initiate | Buy |
| 2024-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-05-16 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-03-21 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-11-14 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-08-24 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-07-18 | Benchmark | Initiate | Speculative Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.11
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 79.88%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
23.42%
EPS (3 Months)
-1,814.59%
Next Earnings Summary
INTS is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -1.11 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 115.50% | N/A 62.56% | N/A -48.62% | N/A 37.39% | N/A 22.69% | |||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.223M | -8.014M -28.77% | -7.55M 5.79% | -8.319M -10.19% | -16.585M -99.36% | -11.972M 27.81% | N/A -5.93% | N/A -28.19% | N/A 24.63% | N/A 313.18% | N/A 224.18% | N/A -26.15% | N/A 44.61% | N/A 25.37% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -29.25 11.08% | -11.56 60.48% | N/A 65.21% | N/A -7.90% | N/A -23.74% | N/A 239.03% | N/A 76.78% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.11 79.88% | -0.99 69.48% | -0.94 37.44% | -0.95 27.20% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.984M 12.07% | -3.107M -14.86% | -3.189M -16.68% | -3.254M -3.62% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
15.37%
EPS Next 5 Year
25.73%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INTENSITY THERAPEUTICS INC / INTS Forecast FAQ
Can you provide the upcoming earnings date for INTENSITY THERAPEUTICS INC?
INTENSITY THERAPEUTICS INC (INTS) will report earnings on 2026-05-07.
Can you provide the consensus estimates for INTENSITY THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of INTENSITY THERAPEUTICS INC (INTS) is -1.11 USD and the consensus revenue estimate is 0 USD.